Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RCK is an Israeli cannabis genetics and breeding company focused on developing tailor-made medical cannabis strains, elite hybrid seeds, and propagation materials for commercial growers. The company applies a non-GMO, science-based platform that combines traditional breeding with genome sequencing, DNA analysis, metabolomics-assisted selection, and marker-assisted breeding to control cannabinoid and terpene profiles. RCK markets stable hybrid seeds, mother plants, plantlets, and seedlings, and also provides custom breeding services for medical and commercial applications. Its work spans high-THC, high-CBD, and balanced THC/CBD chemovars intended to meet Israeli medical cannabis standards and broader international cultivation needs. The company also positions itself as an R&D partner for cannabis agtech innovation and academic or medical collaborations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RCK.